{"count": 3, "results": [{"_id": "35732105", "pmid": 35732105, "title": "Simple and rapid quantification of cetirizine, venlafaxine, and O-desmethylvenlafaxine in human breast milk, and metformin in human milk and plasma with UHPLC-MS/MS.", "journal": "J Chromatogr B Analyt Technol Biomed Life Sci", "authors": ["Wegler C", "Saleh A", "Lindqvist A", "Nordeng H", "Smeraglia J", "Baranczewski P"], "date": "2022-08-01T00:00:00Z", "doi": "10.1016/j.jchromb.2022.123340", "meta_date_publication": "2022 Aug 1", "meta_volume": "1205", "meta_issue": "", "meta_pages": "123340", "score": 50244.816, "text_hl": "Complications such as @DISEASE_Drug_Hypersensitivity @DISEASE_MESH:D004342 @@@allergies@@@, @<m>DISEASE_Depression_Postpartum</m> @DISEASE_MESH:D019052 @@@postpartum depression@@@, and @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ are often treated with drugs such as @CHEMICAL_Cetirizine @CHEMICAL_MESH:D017332 @@@cetirizine@@@, @CHEMICAL_Venlafaxine_Hydrochloride @CHEMICAL_MESH:D000069470 @@@venlafaxine@@@, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, respectively. ", "citations": {"NLM": "Wegler C, Saleh A, Lindqvist A, Nordeng H, Smeraglia J, Baranczewski P. Simple and rapid quantification of cetirizine, venlafaxine, and O-desmethylvenlafaxine in human breast milk, and metformin in human milk and plasma with UHPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Aug 1;1205():123340. PMID: 35732105", "BibTeX": "@article{35732105, title={Simple and rapid quantification of cetirizine, venlafaxine, and O-desmethylvenlafaxine in human breast milk, and metformin in human milk and plasma with UHPLC-MS/MS.}, author={Wegler C and Saleh A and Lindqvist A and Nordeng H and Smeraglia J and Baranczewski P}, journal={J Chromatogr B Analyt Technol Biomed Life Sci}, volume={1205}, pages={123340}}"}}, {"_id": "29103210", "pmid": 29103210, "title": "Insulin for the treatment of women with gestational diabetes.", "journal": "Cochrane Database Syst Rev", "authors": ["Brown J", "Grzeskowiak L", "Williamson K", "Downie MR", "Crowther CA"], "date": "2017-11-05T00:00:00Z", "doi": "10.1002/14651858.CD012037.pub2", "meta_date_publication": "2017 Nov 5", "meta_volume": "11", "meta_issue": "11", "meta_pages": "CD012037", "score": 50017.7, "text_hl": "There was no clear evidence of difference in postnatal weight retention between @SPECIES_9606 @@@women@@@ treated with @GENE_INS @GENE_3630 @@@insulin@@@ and those treated with oral anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ pharmacological therapy (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@) at six to eight weeks postpartum (MD -1.60 kg, 95% CI -6.34 to 3.14; one study, 167 @SPECIES_9606 @@@women@@@; low-quality evidence) or one year postpartum (MD -3.70, 95% CI -8.50 to 1.10; one study, 176 @SPECIES_9606 @@@women@@@; low-quality evidence). ", "citations": {"NLM": "Brown J, Grzeskowiak L, Williamson K, Downie MR, Crowther CA. Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev. 2017 Nov 5;11(11):CD012037. PMID: 29103210", "BibTeX": "@article{29103210, title={Insulin for the treatment of women with gestational diabetes.}, author={Brown J and Grzeskowiak L and Williamson K and Downie MR and Crowther CA}, journal={Cochrane Database Syst Rev}, volume={11}, number={11}, pages={CD012037}}"}}, {"_id": "30103263", "pmid": 30103263, "title": "Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews.", "journal": "Cochrane Database Syst Rev", "authors": ["Martis R", "Crowther CA", "Shepherd E", "Alsweiler J", "Downie MR", "Brown J"], "date": "2018-08-14T00:00:00Z", "doi": "10.1002/14651858.CD012327.pub2", "meta_date_publication": "2018 Aug 14", "meta_volume": "8", "meta_issue": "8", "meta_pages": "CD012327", "score": 50016.266, "text_hl": "@CHEMICAL_Insulin @CHEMICAL_MESH:D007328 @@@Insulin@@@ versus insulinThe evidence for insulin aspart versus @CHEMICAL_Insulin_Lispro @CHEMICAL_MESH:D061268 @@@lispro@@@ for risk of caesarean section was inconclusive (RR 1.00, 95% CI 0.91 to 1.09; 3 RCTs, N = 410; GRADE moderate quality).No conclusions possibleNo conclusions were possible for: lifestyle versus usual care (@DISEASE_Neuralgia @DISEASE_MESH:D009437 @@@perineal trauma@@@, @<m>DISEASE_Depression_Postpartum</m> @DISEASE_MESH:D019052 @@@postnatal depression@@@, neonatal @DISEASE_Neoplasms_Adipose_Tissue @DISEASE_MESH:D018205 @@@adiposity@@@, number of antenatal visits/admissions); diet versus control (@DISEASE_Pre_Eclampsia @DISEASE_MESH:D011225 @@@pre-eclampsia@@@, caesarean section); @CHEMICAL_Inositol @CHEMICAL_MESH:D007294 @@@myo-inositol@@@ versus placebo (hypoglycaemia); @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ versus @CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glibenclamide@@@ (@DISEASE_Hypertension_Pregnancy_Induced @DISEASE_MESH:D046110 @@@hypertensive disorders of pregnancy@@@, pregnancy-induced @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@, @DISEASE_Death @DISEASE_MESH:D003643 @@@death@@@ or serious morbidity composite, @CHEMICAL_Insulin @CHEMICAL_MESH:D007328 @@@insulin@@@ versus oral therapy (development of @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@); intensive management versus routine care (IOL, large-for-gestational age); post- versus pre-prandial @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ monitoring (large-for-gestational age). ", "citations": {"NLM": "Martis R, Crowther CA, Shepherd E, Alsweiler J, Downie MR, Brown J. Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2018 Aug 14;8(8):CD012327. PMID: 30103263", "BibTeX": "@article{30103263, title={Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews.}, author={Martis R and Crowther CA and Shepherd E and Alsweiler J and Downie MR and Brown J}, journal={Cochrane Database Syst Rev}, volume={8}, number={8}, pages={CD012327}}"}}]}